Uses of the drug Vasartem 80

Vasartim 80 is known to treat high blood pressure and other conditions such as heart failure. Vasartim 80 is prepared and packaged in the form of film-coated tablets, containing the main ingredient ValSarfan.

Vasartim 80 has the main ingredient is Valsartan with the concentration in each tablet is 80mg and excipients such as microcrystalline cellulose, crospovidone, anhydrous colloidal silicon oxide, magnesium stearate, sato oxide and opadry II white. So what does Vasartim 80 do?
Valsartan in the drug Vasartim 80 is commonly used in the treatment of hypertension and heart failure. Valsartan belongs to a class of known as angiotensin receptor blockers (ARBs), which work by dilating blood vessels so that it flows more easily.
Eucaphar is indicated for use in children over 6 years old and adults in the following cases:
Symptomatic treatment of hypertension or heart failure; Support recovery after myocardial infarction: patients need to be clinically stable and have left ventricular failure or reduced left ventricular function after myocardial infarction. According to doctors, Vasartim 80 is contraindicated for use in subjects such as:
Hypersensitivity to Valsartan or to any of the excipients included in the drug formula; Severe liver failure, biliary cirrhosis or cholestatic liver; Women who are in the second and third trimesters of pregnancy.

How to use: Vasartim 80 is packaged in the form of film-coated tablets, so the drug is indicated for oral use.
Dosage for adults:
Hypertension: Initial dose is 80 - 160mg/time/day if used as monotherapy and should be used at a lower dose if concomitantly with diuretics. The maximum dose that can be used is 320mg/day. Heart failure: Initial dose is 40mg/twice/day, dose may be increased to 80-160mg/times/day, lower dose if used with diuretics. The maximum dose is 320mg/day. After MI: Vasartim 80 can be started as early as 12 hours after MI in clinically stable patients. The recommended starting dose is 20mg twice a day. This dose should be adjusted within 7 days of dosing, up to 40 mg twice daily, then titrated to a maintenance dose up to 160 mg twice daily, depending on the dose. patient tolerance. Elderly: No dosage adjustment is required for elderly patients. Renal impairment: No dose adjustment is required for patients with creatinine clearance > 10ml/min. Hepatic impairment: In patients with mild to moderate hepatic impairment and without cholestasis, the maximum dose of Vasartim 80 is 80 mg. Dosage for children from 6 to 16 years of age with increased blood pressure:
Children can swallow whole tablets: The starting dose is usually 1.3mg/kg x 1 time/day (total dose) maximum use up to 40mg). The specific dose should be adjusted depending on the patient's blood pressure. There are no data indicating a dose of 2.7 mg/kg (up to 160 mg) for children 6 to 16 years of age. Missed dose: If a dose of Vasartim 80 is discovered, it should be taken as soon as possible. But in case it is almost time for your next dose, skip the missed dose and take your next dose as scheduled. Do not take twice the recommended dose.
Overdose : The most common manifestations of an overdose of Vasartim 80 will be hypotension and tachycardia, bradycardia may occur when there is parasympathetic stimulation. In addition, depression, circulatory collapse and shock were found. If there are abnormal manifestations due to drug overdose, stop using the drug and take the patient to the nearest medical facility for treatment support.

When using Vasartim 80, you may experience some unwanted side effects such as:
Common side effects:
Dizziness, headache, abdominal pain, edema, back pain, sore throat, fatigue fatigue, upper respiratory tract infection, decreased blood pressure, hyperkalemia, dry cough, myalgia, gastrointestinal disturbances, constipation, diarrhea, sinusitis, nausea, arthralgia, palpitations, itching, development rash, dry mouth, indigestion, flatulence, anxiety, insomnia. Uncommon side effects:
Dizziness, cough, abdominal pain, fatigue. Rare side effects:
Angioedema, hepatitis, thrombocytopenia, rhabdomyolysis. *Note: When experiencing the above symptoms or any other symptoms not on the list listed above, which is suspected to be caused by the use of Vasartim 80, temporarily stop using the drug and notify Ask your doctor for a dose adjustment.

Cases requiring caution when using Vasartim 80 for the following cases:
Hyperkalemia: Concomitant use with potassium supplements, potassium-sparing diuretics, potassium-containing salts or agents other increases in potassium levels (heparin, ..) not recommended by your doctor; Patients with intravascular volume depletion (eg due to high doses of diuretics); Renal artery stenosis or severe kidney failure; Renal Transplant Patients: There are no data or reports on the safe use of Vasartim 80 in patients who have recently undergone kidney transplantation; Patients with primary hyperaldosteronism: Treatment with valsartan is not recommended because the renin-angiotensin system is not activated; Hepatic impairment: In patients with mild hepatic impairment and no cholestasis, use Vasartim 80 with caution; Treatment of myocardial infarction: Concomitant use of valsartan with ACE inhibitors is not recommended because of the increased risk of adverse events; Heart failure: Concomitant use of 3 drugs, ACE inhibitors, beta blockers and valsartan is not recommended because of the increased risk of adverse events; Pregnancy or breast-feeding: Use of specific angiotensin II receptor antagonists is not recommended during pregnancy. Because there is no information on the use of valsartan in women during lactation, valsartan is not recommended during this time to ensure the safety of mother and baby; Effects of the drug on driving and operating machinery: There is no information on the effect of the drug on the process of operating machinery.

Lithium: Reversible increases in serum lithium concentrations and lithium toxicity have been reported with concomitant use of ACE inhibitors. Due to the lack of information on the co-administration of valsartan with lithium, this combination is not recommended for patients to do; Potassium-sparing diuretics or potassium supplements and potassium-containing salts can cause an increase in potassium levels; Concomitant use of Vasartim 80 with non-steroidal anti-inflammatory drugs may increase the risk of worsening renal function and increase serum potassium levels. The article has provided information about the uses, dosage and precautions when using Vasartim 80. To ensure safety for health and maximize the effectiveness of treatment, patients need to take Vasartim 80 exactly as directed by their doctor.